D. W. Gammon et al. / Tetrahedron Letters 45 (2004) 9533–9536
9535
was added NH4I (64mg, 0.44mmol), and Ac2O (0.5mL)
and the resulting mixture cooled to 0ꢁC. H2O2 (25lL of a
50% aqueous solution in water, 0.44mmol) was added and
the solution stirred for 1h at 0ꢁC, when TLC showed the
reaction was complete. A 0.1M solution of sodium
thiosulfate was then added until the brownish colour
disappeared, and the solution was cooled in an ice-water
bath before adding cold 10% aq NaOH until the solution
became slightly basic. The resultant mixture was extracted
with ethylacetate, and the combined organic phases
washed once with brine, then dried (MgSO4) and concen-
trated. Separation of the product mixture by chromato-
graphy on silica gel yielded the pure isomers 9a (144mg,
70%) and 9b (30mg, 15%).
solutions upon addition of H2O2 to the other reactants
suggests the presence of molecular I2, formed either by
reaction of IÀ with H2O2 under acidic conditions17,18
or by reaction of IÀ with peracetic acid, generated upon
addition of H2O2 to acetic anhydride in the presence of
acetic acid.19 It is possible that an initial and rapid for-
mation of a p-complex between the olefin and I2 is fol-
lowed by a rate-determining abstraction of IÀ by the
peracetic acid.19 The high degree of stereoselectivity in
solvolysis of the resulting iodonium species and the fact
that in the absence of acetic anhydride the iodoacetates
predominate over iodohydrins suggests that acetic acid
attacks the iodonium species directly. The presence of
an excess of acetic anhydride ensures that the concentra-
tion of water in the reaction mixture is minimized,
allowing for successful addition of the acetate or acetic
acid to the cyclic iodonium species.
14. Analytical data for known compounds 9a, 9b, 10a, 10b,
13a, 13b, 14a, 14b, 15a, 15b, 16a, 16b and 16c were
consistent with published data (Refs. 5, 7, 14, 15 and 16);
data for new compounds is as follows. 11a: mp 153–
155ꢁC. 1H NMR (300MHz, CDCl3): d 7.77–7.34 (m, 10H,
2 · Ph), 6.45 (d, 1H, J = 1.5Hz, H-1), 5.63 (t, 1H,
J = 9.6Hz, H-4), 4.60 (dd, 1H, J = 4.2, 9.6Hz, H-3), 4.52
(dd, 1H, J = 1.5, 4.2Hz, H-2), 3.98–3.92 (m, 1H, H-5),
3.72 (d, 2H, J = 2.7Hz, H-6a and H-6b), 2.12, 2.09, 1.93
(3s, 9H, 3 · CH3CO2), 1.08 (s, 9H, Me3C–Si). 13C NMR
(100MHz, CDCl3): d 170.0, 169.0, 168.2 (3 · CH3CO2),
135.8, 135.7, 133.2, 133.1, 129.7, 129.6, 127.6 (2 · Ph), 95.0
(C-1), 74.0 (C-5), 69.2 (C-3), 67.1 (C-4), 62.0 (C-6), 27.3
(C-2), 26.7 (Me3C–Si), 20.9, 20.8, 20.5 (3 · CH3CO2), 19.2
(Me3C–Si). IR (cmÀ1): 3004, 2933, 2859, 2346, 1751, 1473,
1429, 1371, 1299, 1240, 1220, 1142, 1112, 1062, 1008, 977,
942. Anal. Calcd for C28H35IO8Si: C, 51.38; H, 5.39.
Found: C, 51.42; H, 5.31.
In summary, we have shown that the simple, cost effec-
tive and environmentally benign combination of NH4I
(or NH4Br), 50% aq H2O2 and Ac2O/AcOH in CH3CN
at low temperatures achieves efficient and highly stereo-
selective haloacetoxylation of protected glycals. The
application of this methodology to a wider range of ole-
fins is currently being investigated, together with its
compatibility with a wider array of protecting groups,
and will be reported later in full.
1
11b: H NMR (300MHz, CDCl3): d 7.67–7.33 (m, 10H,
Acknowledgements
2 · Ph), 5.87 (d, 1H, J = 9.3Hz, H-1), 5.30 (dd, 1H,
J = 9.3, 11.2Hz, H-4), 5.12 (t, 1H, J = 9.3Hz, H-3), 3.98
(dd, 1H, J = 9.3, 11Hz, H-2), 3.80–3.65 (m, 3H, H-5, H-6a
and H-6b), 2.18, 2.09, 1.89 (3s, 9H, 3 · CH3CO2), 1.04 (s,
9H, Me3C–Si). 13C NMR (100MHz, CDCl3): d 169.6,
169.3, 168.4 (3 · CH3CO2), 136.0, 135.6, 133.1, 133.0,
129.7, 129.6, 127.7, 127.6, 127.5 (2 · Ph), 94.0 (C-1), 75.7,
75.4 (C-3 and C-5), 68.8 (C-4), 62.2 (C-6), 29.7 (C-2), 26.7
(Me3C–Si), 20.7, 20.6, 20.5 (3 · CH3CO2), 19.2 (Me3C–
Si). IR (cmÀ1): 3075, 2995, 2930, 2857, 2346, 1759, 1464,
1428, 1366, 1271, 1267, 1263, 1260, 1238, 1217, 1113, 1058,
1007, 904, 889. Anal. Calcd for C28H35IO8Si: C, 51.38; H,
5.39. Found: C, 51.50; H, 5.55.
We thank the NRF (South Africa) and the Ministry of
the Flemish Community (Flanders, Belgium) for finan-
cialsupport for this research under the RSA-Felmish
Community bilateral agreement.
References and notes
´
1. Barluenga, J.; Marco-Arias, M.; Gonzales-Bobes, F.;
Ballesteros, A. Chem. Eur. J. 2004, 10, 1677–1682.
2. Roush, W. R.; Narayan, S. Org. Lett. 1999, 1, 899–902.
3. Durham, T. B.; Roush, W. R. Org. Lett. 2003, 5, 1871–
1874.
4. Gammon, D. W.; Hunter, R.; Steenkamp, D. J.; Mud-
zunga, T. T. Bioorg. Med. Chem. Lett. 2003, 13, 2045–
2049.
5. Sels, B. F.; De Vos, D. E.; Jacobs, P. A. J. Am. Chem. Soc.
2001, 123, 8350–8359.
6. Binkley, R. W.; Ambrose, M. G.; Hehemann, D. G. J.
Carbohydr. Chem. 1987, 6, 203–219.
7. Djurendic, E.; Vukojevic, N.; Dramicanin, T.; Canadi, J.;
Miljkovic, D. J. Serb. Chem. Soc. 1998, 63, 685–688.
8. Chong, P. Y.; Roush, W. R. Org. Lett. 2002, 4, 4523–4526.
9. Higgs, D. E.; Neen, M. I.; Detty, M. R. Org. Lett. 2000, 3,
349–352.
10. Sels, B. F.; Brosius, R.; De Vos, D. E.; Jacobs, P. A.;
Gammon, D. W.; Kinfe, H. H. Adv. Synth. Catal., in
press.
11. Lubbecke, H.; Boldt, P. Tetrahedron 1978, 34, 1577–1579.
12. Sempere C. J.; Nomen Ribe, R.; Serra Hosta, E.; Lopez
Belmonte, L., ES Patent number WO 2004/014829 A1,
2004.
13. A representative procedure is as follows: To a solution of
glucal 1 (100mg, 0.37mmol) in AcOH/CH3CN (1:1, 2mL)
12a:1H NMR (400MHz, CDCl3): d 7.77–7.18 (m, 20H,
4 · Ph), 6.45 (d, 1H, J = 1.6Hz, H-1), 4.97 (d, 1H,
J = 10.4Hz, CH2Ph), 4.74 (d, 1H, J = 11.6Hz, CH2Ph),
4.65 (d, 1H, J = 10.4Hz, CH2Ph), 4.57 (d, 1H, J = 11.6Hz,
CH2Ph), 4.48 (dd, 1H, J = 1.6, 4.4Hz, H-2), 4.26 (t, 1H,
J = 9.4Hz, H-4), 4.00 (dd, 1H, J = 3.2, 11.6Hz, H-6a),
3.88–3.82 (m, 2H, H-5 and H-6b), 3.25 (m, 1H, H-3), 2.01
(s, 3H, CH3CO2), 1.11 (s, 9H, Me3C–Si). 13C NMR
(100MHz, CDCl3): d 168.5 (CH3CO2), 135.9, 135.7, 129.6,
129.5, 128.5, 128.4, 128.1, 128.0, 127.9, 127.7, 127.6, 127.5
(4 · Ph), 95.8 (C-1), 75.5, 75.5, 75.1 (C-3, C-4, C-5,
CH2Ph), 71.2 (CH2Ph), 62.2 (C-6), 31.1 (C-2), 26.9
(Me3C–Si), 20.8 (CH3CO2), 19.3 (Me3C–Si). IR (cmÀ1):
3071, 3033, 3000, 2933, 2860, 2585, 2346, 1750, 1589, 1497,
1473, 1455, 1428, 1371, 1295, 1272, 1269, 1265, 1261, 1259,
1219, 1143, 1112, 1028, 1000, 937, 868. Anal. Calcd for
C38H43IO6Si: C, 60.79; H, 5.77. Found: C, 61.14; H, 5.94.
1
12b: H NMR (400MHz, CDCl3): d 7.70–7.21 (m, 20H,
4 · Ph), 5,84 (d, 1H, J = 9.6Hz, H-1), 4.98 (d, 1H,
J = 10Hz, CH2Ph), 4.91 (d, 1H, J = 4Hz, CH2Ph), 4.89
(d, 1H, J = 4.4Hz, CH2Ph), 4.77 (d, 1H, J = 10.8Hz,
CH2Ph), 4.00 (dd, 1H, J = 9.6, 10.4Hz, H-2), 3.95 (m, 2H,
H-6a and H-6b), 3.87 (t, 1H, J = 9Hz, H-4), 3.78 (dd, 1H,